Please provide your email address to receive an email when new articles are posted on . Improving diversity in cancer clinical trial enrollment has become an increased priority among oncology ...
The phase 3 Pragmatica-Lung study evaluating Cyramza and Keytruda has broader eligibility criteria than many other trials, expanding access to more patients and clinicians. The National Cancer ...
Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement Clinical trial eligibility ...
The guidances released by the FDA to expand inclusion criteria for cancer clinical trials is a step in the right direction, said Katie Goodman, RN, BSN, CCRP, director of clinical research, Florida ...
Clinical trial criteria is really about patient safety and making sure participating patients don't experience undue risks, explained Katie Goodman, RN, BSN, CCRP, director of clinical research, ...
The primary purposes of eligibility criteria are to protect the safety of trial participants and define the trial population. Excessive or overly restrictive eligibility criteria can slow trial ...
New analysis of real-world data from the largest US Lyme disease registry, MyLymeData, has shown that most persistent Lyme ...
New data show a large percentage of people with moderate to severe lupus are unable to take part in clinical research trials due to restrictive eligibility criteria – characteristics that must be ...
ATLANTA — Limited access to supportive laboratory assays in developing countries significantly reduces the diagnostic utility of the ACR/EULAR criteria for systemic lupus erythematosus, which relies ...
(RTTNews) - SAB Biotherapeutics, Inc. (SABS), a clinical-stage, biopharmaceutical company focused on human polyclonal antibodies, reported Monday positive Phase 2 safety and efficacy data of SAB-185.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback